Search by Drug Name or NDC
NDC 58809-0729-04 Nasopen 10; 50 mg/15mL; mg/15mL Details
Nasopen 10; 50 mg/15mL; mg/15mL
Nasopen is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by GM Pharmaceuticals, INC. The primary component is PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE.
Product Information
| NDC | 58809-0729 |
|---|---|
| Product ID | 58809-729_0b281455-f2ce-fe79-e063-6394a90aadd6 |
| Associated GPIs | 43993002860920 |
| GCN Sequence Number | 069572 |
| GCN Sequence Number Description | thonzylamine/phenylephrine LIQUID 50-10MG/15 ORAL |
| HIC3 | Z2N |
| HIC3 Description | 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION |
| GCN | 32676 |
| HICL Sequence Number | 039316 |
| HICL Sequence Number Description | THONZYLAMINE HCL/PHENYLEPHRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Nasopen |
| Proprietary Name Suffix | PE |
| Non-Proprietary Name | Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 10; 50 |
| Active Ingredient Units | mg/15mL; mg/15mL |
| Substance Name | PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE |
| Labeler Name | GM Pharmaceuticals, INC |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | n/a |
Package
NDC 58809-0729-04 (58809072904)
| NDC Package Code | 58809-729-04 |
|---|---|
| Billing NDC | 58809072904 |
| Package | 118 mL in 1 BOTTLE (58809-729-04) |
| Marketing Start Date | 2012-10-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |